Laura E. Raffals

3.4k total citations · 1 hit paper
100 papers, 2.2k citations indexed

About

Laura E. Raffals is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Laura E. Raffals has authored 100 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Genetics, 71 papers in Epidemiology and 39 papers in Surgery. Recurrent topics in Laura E. Raffals's work include Inflammatory Bowel Disease (79 papers), Microscopic Colitis (57 papers) and Eosinophilic Esophagitis (17 papers). Laura E. Raffals is often cited by papers focused on Inflammatory Bowel Disease (79 papers), Microscopic Colitis (57 papers) and Eosinophilic Esophagitis (17 papers). Laura E. Raffals collaborates with scholars based in United States, Canada and United Kingdom. Laura E. Raffals's co-authors include Edward V. Loftus, Amy L. Lightner, Kellie L. Mathis, Kevin P. Quinn, Edward L. Barnes, William A. Faubion, Chung Sang Tse, Corey A. Siegel, Nicholas P. McKenna and Gilaad G. Kaplan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and The American Journal of Gastroenterology.

In The Last Decade

Laura E. Raffals

95 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases

2019 228 citations Adam S. Cheifetz, Gil Melmed et al. Clinical Gastroenterology and Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Laura E. Raffals United States	26	1.5k	1.2k	719	353	254	100	2.2k
Míriam Mañosa Spain	28	1.5k 1.0×	1.2k 1.0×	763 1.1×	348 1.0×	210 0.8×	129	2.2k
Guillaume Bouguen France	30	1.8k 1.2×	1.3k 1.1×	1.3k 1.9×	288 0.8×	250 1.0×	144	2.8k
Mary Zachos Canada	17	1.6k 1.1×	1.1k 0.9×	792 1.1×	360 1.0×	190 0.7×	39	2.3k
Javier Martín de Carpi Spain	14	1.1k 0.7×	729 0.6×	650 0.9×	266 0.8×	146 0.6×	57	1.6k
Russell S. Walmsley United Kingdom	14	1.2k 0.8×	963 0.8×	577 0.8×	217 0.6×	337 1.3×	22	2.1k
Talat Bessissow Canada	29	2.0k 1.4×	1.8k 1.5×	1.1k 1.5×	389 1.1×	361 1.4×	204	3.0k
Jérôme Filippi France	21	1.0k 0.7×	799 0.7×	729 1.0×	207 0.6×	467 1.8×	58	2.1k
Marte Lie Høivik Norway	21	1.0k 0.7×	1.0k 0.8×	435 0.6×	267 0.8×	157 0.6×	63	1.8k
Magne Henriksen Norway	21	2.3k 1.6×	2.0k 1.6×	939 1.3×	219 0.6×	260 1.0×	31	2.8k
Abderrahim Oussalah France	27	1.2k 0.8×	1.1k 0.9×	536 0.7×	270 0.8×	87 0.3×	84	2.4k

Countries citing papers authored by Laura E. Raffals

Since Specialization

Citations

This map shows the geographic impact of Laura E. Raffals's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura E. Raffals with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura E. Raffals more than expected).

Fields of papers citing papers by Laura E. Raffals

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura E. Raffals. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura E. Raffals. The network helps show where Laura E. Raffals may publish in the future.

Co-authorship network of co-authors of Laura E. Raffals

This figure shows the co-authorship network connecting the top 25 collaborators of Laura E. Raffals. A scholar is included among the top collaborators of Laura E. Raffals based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura E. Raffals. Laura E. Raffals is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Barnes, Edward L., Laura E. Raffals, Taha Qazi, et al.. (2025). A Prospective Comparison of Ustekinumab and Antitumor Necrosis Factor α Therapy in the Treatment of Crohn's-Like Disease of the Pouch. The American Journal of Gastroenterology.

Kayal, Maia, Elizabeth A. Spencer, Matthew D. Smyth, et al.. (2024). Risankizumab Is Effective for The Management of Crohn’s Disease of the Pouch. Inflammatory Bowel Diseases. 31(3). 878–881. 1 indexed citations

Dunleavy, Katie A., et al.. (2024). P1175 Abdominal Pain is Associated with Poor Quality of Life in Quiescent Inflammatory Bowel Disease: A Cross-sectional Study of the SPARC Inflammatory Bowel Disease Cohort. Journal of Crohn s and Colitis. 18(Supplement_1). i2082–i2084.

Dulai, Parambir S., Lauren C. Balmert, Laura E. Raffals, et al.. (2024). Clinical Trial Design Considerations for Hospitalised Patients With Ulcerative Colitis Flares and Application to Study Hyperbaric Oxygen Therapy in the NIDDK HBOT‐UC Consortium. Alimentary Pharmacology & Therapeutics. 60(11-12). 1512–1524.

Kayal, Maia, Parakkal Deepak, Poonam Beniwal‐Patel, et al.. (2023). Changes in Therapy Are Not Associated With Increased Remission in Patients With Crohn's Disease of the Pouch. The American Journal of Gastroenterology. 119(3). 584–587. 4 indexed citations

Coelho‐Prabhu, Nayantara, Ryan J. Lennon, Jessica Friton, et al.. (2023). Baseline Clinical Factors Are Associated With Risk of Complications in Crohn's Disease: Appraisal of the American Gastroenterological Association Clinical Care Pathway. The American Journal of Gastroenterology. 119(1). 147–154. 2 indexed citations

Vinsard, Daniela Guerrero, et al.. (2023). Measuring the concordance between endoscopic and histologic inflammation and its effect on IBD-associated dysplasia. SHILAP Revista de lepidopterología. 12(1). E145–E154. 3 indexed citations

Barnes, Edward L., Manasi Agrawal, Gaurav Syal, et al.. (2023). AGA Clinical Practice Guideline on the Management of Pouchitis and Inflammatory Pouch Disorders. Gastroenterology. 166(1). 59–85. 50 indexed citations

Wang, Ming‐Hsi, Jessica Friton, Laura E. Raffals, et al.. (2023). Polygenic risk score predicts risk of primary sclerosing cholangitis in inflammatory bowel disease. BMJ Open Gastroenterology. 10(1). e001141–e001141. 3 indexed citations

10.

Dulai, Parambir S., Victoria Rai, Laura E. Raffals, et al.. (2022). Recommendations on the Appropriate Management of Steroids and Discharge Planning During and After Hospital Admission for Moderate-Severe Ulcerative Colitis: Results of a RAND Appropriateness Panel. The American Journal of Gastroenterology. 117(8). 1288–1295. 5 indexed citations

11.

Fredrick, Thomas, Guilherme Piovezani Ramos, Manuel B. Braga Neto, et al.. (2022). Clinical Course and Impact of Immune Checkpoint Inhibitor Colitis Resembling Microscopic Colitis. Crohn s & Colitis 360. 4(2). otac008–otac008. 4 indexed citations

12.

Ramos, Guilherme Piovezani, Badr Al‐Bawardy, Manuel B. Braga Neto, et al.. (2021). Certolizumab Trough Levels and Antibodies in Crohn Disease: A Single-Center Experience. Crohn s & Colitis 360. 3(3). otab019–otab019. 2 indexed citations

13.

Vasudevan, Abhinav, David H. Bruining, Edward V. Loftus, et al.. (2021). Approach to medical therapy in perianal Crohn’s disease. World Journal of Gastroenterology. 27(25). 3693–3704. 16 indexed citations

14.

Ramos, Guilherme Piovezani, Deborah D. Proctor, Elizabeth Ruggiero, et al.. (2020). The Impact of Vedolizumab on Pre-Existing Extraintestinal Manifestations of Inflammatory Bowel Disease: A Multicenter Study. Inflammatory Bowel Diseases. 27(8). 1270–1276. 14 indexed citations

15.

Chedid, Victor, et al.. (2019). De Novo Colitis Associated With Rituximab in 21 Patients at a Tertiary Center. Clinical Gastroenterology and Hepatology. 18(1). 252–253. 42 indexed citations

16.

Raffals, Laura E., Geoffrey C. Nguyen, & David T. Rubin. (2018). Switching Between Biologics and Biosimilars in Inflammatory Bowel Disease. Clinical Gastroenterology and Hepatology. 17(5). 818–823. 13 indexed citations

17.

Dulai, Parambir S., Jay C. Buckey, Laura E. Raffals, et al.. (2018). Hyperbaric oxygen therapy is well tolerated and effective for ulcerative colitis patients hospitalized for moderate-severe flares: a phase 2A pilot multi-center, randomized, double-blind, sham-controlled trial. The American Journal of Gastroenterology. 113(10). 1516–1523. 46 indexed citations

18.

Melmed, Gil, Gilaad G. Kaplan, Miles Sparrow, et al.. (2018). Appropriateness of Combination Therapy for Patients With Inflammatory Bowel Diseases: One Size Still Does Not Fit All. Clinical Gastroenterology and Hepatology. 16(11). 1829–1831. 4 indexed citations

19.

Lightner, Amy L., et al.. (2017). Surgical Outcomes in Vedolizumab-Treated Patients with Ulcerative Colitis. Inflammatory Bowel Diseases. 23(12). 2197–2201. 42 indexed citations

20.

Felice, Kara M. De, David A. Katzka, & Laura E. Raffals. (2015). Crohnʼs Disease of the Esophagus. Inflammatory Bowel Diseases. 21(9). 2106–2113. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact